Lynwood Capital Management Inc. - PHOENIX BIOTECH ACQUISITION ownership

PHOENIX BIOTECH ACQUISITION's ticker is and the CUSIP is 71902K204. A total of 29 filers reported holding PHOENIX BIOTECH ACQUISITION in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Lynwood Capital Management Inc. ownership history of PHOENIX BIOTECH ACQUISITION
ValueSharesWeighting
Q4 2021$252,00025,0000.24%
Other shareholders
PHOENIX BIOTECH ACQUISITION shareholders Q1 2022
NameSharesValueWeighting ↓
Yakira Capital Management, Inc. 100,000$1,031,0000.21%
FLOW TRADERS U.S. LLC 10,247$1040.01%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Tower Research Capital LLC (TRC) 175$20.00%
View complete list of PHOENIX BIOTECH ACQUISITION shareholders